Stay updated on EAP Avapritinib in Advanced GIST Clinical Trial
Sign up to get notified when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.

Latest updates to the EAP Avapritinib in Advanced GIST Clinical Trial page
- Check5 days agoChange DetectedThe new screenshot shows only cosmetic UI/layout updates and does not modify core study information (title, NCT number NCT03862885, condition GIST, Avapritinib dosing, eligibility criteria, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference6%

- Check41 days agoChange DetectedUpdate reflects a new software version (v3.1.0) replacing the old v3.0.2; the page now references the new revision and no longer mentions the previous version.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.4%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.4%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms and resources have been removed.SummaryDifference3%

Stay in the know with updates to EAP Avapritinib in Advanced GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.